<DOC>
	<DOCNO>NCT00831077</DOCNO>
	<brief_summary>The purpose study determine pharmacokinetic parameter ORM-12741 ORM-14540 healthy volunteer .</brief_summary>
	<brief_title>Early Phase I Microdosing Study ORM-14540 ORM-12741</brief_title>
	<detailed_description />
	<criteria>Written inform consent ( IC ) obtain . Good general health ascertain detailed medical history physical examination . Males 18 45 year ( inclusive ) . Body Mass Index ( BMI ) 1830 kg/m2 ( inclusive , BMI = weight/height2 ) . Weight 55100 kg ( inclusive ) . A predictable poor compliance inability communicate well investigator study centre personnel . Veins unsuitable repeated venipuncture Evidence clinically significant cardiovascular , renal , hepatic , haematological , gastrointestinal , pulmonary , metabolicendocrine , neurological , urogenital psychiatric disease judge investigator . Any condition require regular concomitant medication include herbal product likely need concomitant treatment study . Susceptibility severe allergic reaction . Intake medication could affect outcome study , within 2 week prior first study treatment less 5 time halflife medication . Possible enzyme induce drug discuss casebycase sponsor . Regular consumption 21 unit alcohol per week ( 1 unit = 4 cl spirit , 13 g alcohol ) . Current use nicotinecontaining product 5 cigarette equivalent/day . Inability refrain use nicotinecontaining product stay study centre . Inability refrain consume caffeinecontaining beverage stay study centre , e.g . propensity get headache refrain caffeinecontaining beverage . Blood donation loss significant amount blood within 2 month prior screen visit . Abnormal 12lead electrocardiogram ( ECG ) find clinical relevance supine position rest 10 minute screen visit , example : QTc ( calculate Bazett 's formula ) &gt; 450msec , PR &lt; 120 msec &gt; 210 msec , QRS &lt; 70 msec &gt; 120 msec . Heart rate ( HR ) &lt; 45 beats/minute &gt; 100 beats/minute supine position rest 10 minute screen visit . At screen visit , systolic blood pressure ( BP ) &lt; 90 mmHg &gt; 140 mmHg supine position rest 10 minute , diastolic BP &lt; 50 mmHg &gt; 90 mmHg supine position rest 10 minute . Any abnormal value laboratory , vital sign , physical examination , may opinion investigator interfere interpretation test result cause health risk subject take part study . History drug abuse positive result drug abuse test . Positive serology human immunodeficiency virus antigen/antibodies ( HIVAgAb ) , hepatitis C virus antibody ( HCVAb ) hepatitis B surface antigen ( HBsAg ) . Any condition opinion investigator would interfere evaluation result constitute health risk subject . Participation clinical drug study within 3 month prior screen visit study , early participation clinical study ORM12741 . Exposure 14Clabelled drug diagnostics within 12 month prior screen visit . Men practise clinically accept method contraception study next 3 month study treatment administration .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Healthy volunteer</keyword>
</DOC>